According to reports, Angelicin inhibited breast cancer by mitochondria-dependent apoptosis by downregulation of Bcl-2 (apoptosis-regulating gene) and by the upregulation of PI3K/RAC α serine/threonine protein kinase (AKT) signaling pathway which caused breakage of DNA strands30. Here, AKT1 is linked to breast carcinoma.